Carboxymethylethanolamine, a Biomarker of Phospholipid Modification during the Maillard Reaction in Vivo
Open Access
- 1 July 1997
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 272 (28) , 17473-17479
- https://doi.org/10.1074/jbc.272.28.17473
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Role of the Maillard Reaction in Diabetes Mellitus and Diseases of AgingDrugs & Aging, 1996
- The Advanced Glycation End Product, N∊-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation ReactionsJournal of Biological Chemistry, 1996
- Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence.Proceedings of the National Academy of Sciences, 1996
- Chromatographic evidence for amadori product formation in rat liver aminophospholipidsLife Sciences, 1995
- Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.Journal of Clinical Investigation, 1993
- Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1993
- Accumulation of Maillard reaction products in skin collagen in diabetes and aging.Journal of Clinical Investigation, 1993
- Pentosidine Formation in Skin Correlates With Severity of Complications in Individuals With Long-Standing IDDMDiabetes, 1992
- Role of Oxidative Stress in Development of Complications in DiabetesDiabetes, 1991
- The Maillard reaction in vivoZeitschrift Fur Ernahrungswissenschaft, 1991